Ursolic Acid: What the Evidence Actually Says About Apple Peel’s Muscle-Building Compound
Ursolic Acid: What the Evidence Actually Says About Apple Peel’s Muscle-Building Compound
In 2011, a lab at the University of Iowa asked a deceptively simple question: when muscle wastes away — from aging, from bed rest, from disease — which genes switch on, and can any natural compound switch them back off? Christopher Adams and his team answered both. They found the atrophy "signature," screened more than 1,300 compounds against it, and hit on one that reversed it almost perfectly. It wasn't an exotic molecule from a rainforest. It was ursolic acid — the waxy stuff in apple peels and the herb garden. Fifteen years and dozens of studies later, the evidence is in: the mice got stronger and leaner. The humans? That part of the story is more complicated.
📋 Simple Summary
Ursolic acid is a natural compound found in apple peels, rosemary, thyme, and oregano. In lab animals it does something remarkable: it builds muscle, shrinks fat, and improves blood sugar — enough that some researchers call it an "exercise mimetic," meaning it mimics some of what exercise does. The science behind it is solid, and one small human trial found it helped people with metabolic syndrome. But here is the honest part: the few human trials that tested it for muscle gain in active people came back empty, mostly because the doses people take are far lower than the doses that worked in mice, and the body does not absorb it well. Treat ursolic acid as a promising, well-studied compound with real animal evidence and early — but mixed — human results.
The detailed breakdown continues below for those who want the full science.
Published: August 15, 2026
Evidence Tier: 🥈 Silver — strong preclinical mechanism, early and mixed human evidence
Category: Supplements & Compounds
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.
✅ Pros (What the Evidence Supports)
- Strongest benefit: In mice it reliably increases muscle mass and strength, boosts brown fat, and reverses diet-induced obesity, glucose intolerance, and fatty liver — with a well-mapped mechanism.
- Real human metabolic signal: One randomized trial in people with metabolic syndrome (150 mg/day) improved insulin sensitivity and lowered inflammatory markers.
- Excellent safety record: Well tolerated in human trials up to 450 mg/day, with decades of food-use history in apples and herbs.
- Bone and skin bonus: Emerging evidence suggests it may also slow bone loss (osteoporosis models) and reduce skin photoaging.
❌ Cons (What the Evidence Doesn't Support or Warns About)
- Biggest limitation: Human muscle trials have been null — adding ursolic acid to resistance training did not add muscle or strength over training alone.
- Poor bioavailability: It is hard to absorb (low solubility and permeability), which likely explains why human results lag the dramatic mouse data.
- Dose gap: Effective mouse doses translate to far more than the 150–450 mg/day used in human trials.
- No longevity proof in people: Lifespan data exists only in flies and mice — there is zero human evidence it extends life.
What Is Ursolic Acid?
Ursolic acid is a pentacyclic triterpenoid — a large, waxy, fat-soluble molecule built from six small isoprene units arranged into five rings. It is the main ingredient in the whitish film you can wipe off an apple peel, and it appears throughout the herb garden: rosemary, thyme, oregano, sage, basil, and lavender all contain it, as do prunes, cranberries, and hawthorn.
Plants make it for the same reason they make most of these compounds: defense. It is antimicrobial and bitter-tasting, and it helps the plant tolerate drought and heat. In 2004 it was approved as an emulsifier for food and cosmetics, where it has a long history of safe use.
What turned ursolic acid from a cosmetic ingredient into a longevity research target was a 2011 study that found it does something much more interesting inside animal cells: it builds muscle.
How It Works
The story begins with muscle atrophy — the loss of muscle mass and strength that comes with aging, bed rest, fasting, and diseases like cancer and diabetes. This loss is not passive. It is an active, gene-driven program, and in 2011 Christopher Adams and colleagues at the University of Iowa mapped it.
They identified the set of genes that switch on when human muscle wastes away (from fasting and spinal-cord injury), then screened more than 1,300 compounds for anything that pushed that "atrophy signature" back in the healthy direction. One compound stood out: ursolic acid. Feeding it to mice for five weeks increased muscle mass and grip strength and reduced body fat — even without exercise (PMID 21641545).
Over the next decade, researchers mapped the mechanism:
- Akt/mTOR activation: Ursolic acid boosts the Akt–mTOR pathway — the cell's core "build muscle" signal — which increases protein synthesis and muscle fiber size (PMID 21641545).
- Atrophy genes switched off: It suppresses FOXO1 and the muscle-wasting genes atrogin-1 and MuRF1, so muscle stops breaking itself down (PMID 21641545).
- Brown fat and metabolism: It increases brown fat — the "good" fat that burns calories for heat — and improves insulin signaling, which together explain its anti-obesity and anti-diabetic effects (PMID 22745735).
- Anti-inflammatory and antioxidant: It blocks the NF-κB inflammatory pathway and scavenges free radicals, two hallmarks of aging that drive chronic disease (PMID 29719446).
- SIRT1 and "energy sensor" proteins: Later work showed ursolic acid raises SIRT1, SIRT6, PGC-1β, and α-Klotho — proteins tied to metabolism and longevity — in muscle and the hypothalamus (PMID 26898441, PMID 27470332).
Put simply: ursolic acid flips the same "grow and stay lean" switch that resistance training and a healthy metabolism pull, while damping the inflammation and breakdown signals that rise with age. That is why it earned the label "exercise mimetic" — though, as the human trials would later show, that label overpromises.
The Longevity Connection
💪 Muscle and sarcopenia — the core story. This is where ursolic acid is best studied and most relevant to aging. Sarcopenia (age-related muscle loss) predicts disability, falls, and earlier death, and ursolic acid is one of the most consistent muscle-building natural compounds in the animal literature. It increased muscle and grip strength in mice (PMID 21641545), preserved muscle in mouse models of cancer cachexia (PMID 42117587, PMID 37190306), improved muscle in dogs with age-related muscle atrophy (PMID 38254356), and attenuated sarcopenia in diabetic-aged mice through a gut–muscle axis (PMID 40294722). The catch: none of this has reliably translated to humans yet.
🔥 Metabolism, obesity, and fatty liver. In diet-induced obese mice, ursolic acid increased muscle and brown fat while decreasing obesity, glucose intolerance, and fatty liver disease (PMID 22745735). More recent work shows it improves muscle strength, lipid metabolism, and liver steatosis in obese mice (PMID 41097235), protects against alcoholic liver injury (PMID 42167556), and eases vascular calcification — a cardiovascular aging marker — by degrading the DECR1 enzyme (PMID 42034130).
🦴 Bone protection. In preclinical models of osteoporosis, ursolic acid slowed bone loss by boosting autophagy in bone cells (PMID 33065153), a mechanism relevant to the bone thinning that accelerates after menopause.
🧠 Brain and nerve protection. Ursolic acid shows neuroprotective and anti-inflammatory effects in models of Parkinson's and Alzheimer's disease, and reviews flag it as a candidate for age-related neurodegeneration (PMID 29098660, PMID 33820525). This work is early but consistent.
⌛ Lifespan data — thin but positive. In the fruit fly Drosophila melanogaster, dietary ursolic acid improved both healthspan and lifespan in males (PMID 30496629). A 2015 hypothesis paper argued it should be tested as an anti-aging agent in humans precisely because of its muscle-rejuvenating effects (PMID 25976755), but no such human lifespan trial exists.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Kunkel 2011 (PMID 21641545) | Mice (landmark) | Screen of 1,300+ compounds found ursolic acid reverses the muscle-atrophy gene signature; increased muscle and grip strength in mice. |
| Kunkel 2012 (PMID 22745735) | Obese mice | Increased skeletal muscle and brown fat; decreased obesity, glucose intolerance, and fatty liver. |
| Staats 2019 (PMID 30496629) | Fruit flies | Dietary ursolic acid improved healthspan and lifespan in male Drosophila. |
| Ramírez-Rodríguez 2017 (PMID 28598231) | Human RCT (n=24) | 150 mg/day for 12 weeks improved insulin sensitivity and inflammatory markers in people with metabolic syndrome. |
| Lobo 2021 (PMID 32593524) | Human RCT (n=24) | 400 mg/day added no extra muscle or strength in active men already doing resistance training on a high-protein diet. |
| Delpino 2021 (PMID 34330458) | Human RCT (n=26) | No added metabolic benefit over a combined exercise program in postmenopausal women. |
| 2021 Aging RCT (PMID 33799307) | Human RCT (n=82) | A supplement combining ursolic acid with protein, BCAA, and vitamin D improved gait speed in undernourished older adults — but ursolic acid was not isolated. |
| 2024 meta-analysis (PMID 38923885) | 6 human studies | Ursolic acid (50.94–450 mg/day) improved some cardiometabolic risk factors across studies. |
| Adams lab (dogs, 2024) (PMID 38254356) | Dogs with muscle atrophy | Ursolic acid supplement improved muscle mRNA markers and increased voluntary exercise in aged dogs. |
| Cancer cachexia (2026) (PMID 42117587) | Mouse models | Dietary ursolic acid preserved muscle mass and strength in mouse models of cancer cachexia. |
Dosing and Safety
There is no established optimal human dose, because the human evidence is still being built. Here is what the data actually supports:
| Context | Typical Amount | Notes |
|---|---|---|
| Food intake | A few mg per day | Apple peels, rosemary, thyme, oregano, and prunes — far below any therapeutic dose. |
| Human trial doses | 150–450 mg/day | The metabolic-syndrome trial used 150 mg/day; muscle trials used 400 mg/day. No dose proved clearly better. |
| Effective mouse dose (translated) | Roughly 2–3 g/day for a 75 kg adult | Mice received ~200–400 mg/kg/day — far more per body weight than any human trial has used. |
Safety notes:
- Bioavailability is the core problem. Ursolic acid is poorly absorbed — it is classified as a BCS class IV compound (low solubility and low permeability). Taking it with a fatty meal helps, and liposomal or "phytosome" formulations are designed to improve absorption, but head-to-head human data on these forms is limited (PMID 35002719).
- Side effects are mild. In trials up to 450 mg/day for 8–12 weeks, ursolic acid was well tolerated, with occasional mild gastrointestinal upset. A Phase I trial of intravenous liposomal ursolic acid in cancer patients found manageable toxicity (PMID 25866811).
- No long-term safety data. Human studies are short (weeks to months). There is no safety record for multi-year daily use.
- Drug interactions. Ursolic acid may interact with liver enzymes (CYP450) that process some medications, and because it lowers blood sugar, combining it with diabetes medication could in theory cause blood sugar to drop too low. These interactions are theoretical and understudied — but worth flagging.
- Pregnancy and breastfeeding. No safety data exists; avoid during pregnancy and breastfeeding.
❓ Common Questions About Ursolic Acid
What is ursolic acid and how does it work?
Ursolic acid is a waxy plant compound found in apple peels, rosemary, thyme, and oregano. It switches on the body's muscle-building signal (the Akt–mTOR pathway), turns off the genes that break muscle down, and reduces inflammation. This is why researchers describe it as an "exercise mimetic" — it mimics some of the internal effects of exercise.
What does the evidence actually show?
The animal evidence is strong and consistent: ursolic acid builds muscle, reduces fat, and improves metabolism in mice, rats, dogs, and flies, with a lifespan benefit in flies. In humans the picture is mixed — one small trial in people with metabolic syndrome improved insulin sensitivity, but the muscle trials in active people found no added benefit. Overall the evidence is 🥈 Silver: a real mechanism and solid animal data, with early and incomplete human results.
What's the right dose?
Human trials have used 150–450 mg per day, and this is the range most supplements provide. There is no proven optimal dose. Because ursolic acid is poorly absorbed, it is best taken with a meal containing fat, and liposomal or phytosome forms may absorb better — though this is not yet proven in human studies.
What are the risks and side effects?
At the doses studied (up to 450 mg/day for a few months), ursolic acid is well tolerated, with only occasional mild stomach upset. The main real-world limitation is not safety but absorption — the body does not absorb it well. There is no long-term safety data, and it could theoretically interact with diabetes medications or drugs processed by the liver.
Who should avoid it?
Pregnant or breastfeeding women should avoid ursolic acid, because there is no safety data. People taking diabetes medication should be cautious, since it lowers blood sugar and could make levels drop too low in combination. Anyone on prescription drugs processed by the liver should check with their doctor first, given the theoretical interaction risk.
The Bottom Line
The evidence hierarchy is clear: mechanism (strong) > animal data (strong and consistent) > human data (early and mixed). Ursolic acid is a genuinely well-characterized compound with a solid, believable mechanism — it builds muscle and improves metabolism in animals through pathways we understand well. If you are focused on sarcopenia and metabolic aging, it is one of the more credible natural compounds in the pipeline.
But the human results have been underwhelming so far. The headline use — building muscle — has failed to reproduce in the few human trials done, and the one positive metabolic trial was small. The most likely explanations are poor absorption and a large dose gap between mouse studies and human doses. We rate it 🥈 Silver overall: worth watching, and a reasonable "maybe" if you are specifically targeting muscle and metabolic health — but not a proven anti-aging supplement.
Who it's for: people interested in the muscle-and-metabolism side of longevity who understand the human evidence is still catching up to the animal data, and who can accept that the most reliable muscle-preserving tools remain the free ones — resistance training and adequate protein. If you take it, take it with a fatty meal, and keep expectations modest.
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Ursolic acid supplements are not approved to treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting any supplement, especially if you have diabetes, take prescription medication, or are pregnant or breastfeeding. Read our full disclaimer →
Sources
- Kunkel SD, Suneja M, Ebert SM, et al. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab. 2011. PMID 21641545
- Kunkel SD, Elmore CJ, Bongers KS, et al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One. 2012. PMID 22745735
- Staats S, Wagner AE, Lüersen K, et al. Dietary ursolic acid improves health span and life span in male Drosophila melanogaster. Biofactors. 2019. PMID 30496629
- Ramírez-Rodríguez AM, González-Ortiz M, Martínez-Abundis E, Acuña Ortega N. Effect of ursolic acid on metabolic syndrome, insulin sensitivity, and inflammation. J Med Food. 2017. PMID 28598231
- Lobo PCB, Vieira IP, Pichard C, Marques BS. Ursolic acid has no additional effect on muscle strength and mass in active men undergoing a high-protein diet and resistance training: A double-blind and placebo-controlled trial. Clin Nutr. 2021. PMID 32593524
- Delpino FM, et al. No additional effects of ursolic acid supplementation associated with combined exercise program on metabolic syndrome of postmenopausal women: A double-blind, randomized, placebo-controlled trial. Clin Nutr ESPEN. 2021. PMID 34330458
- Ursolic acid-based nutritional supplement improves gait speed and mitochondrial functioning in older adults with undernutrition. Aging (Albany NY). 2021. PMID 33799307
- The effects of ursolic acid on cardiometabolic risk factors: a systematic review and meta-analysis. Future Cardiol. 2024. PMID 38923885
- Anti-inflammatory and antioxidant activity of ursolic acid: a systematic review and meta-analysis. Front Pharmacol. 2023. PMID 37841938
- Ursolic acid induces beneficial changes in skeletal muscle mRNA expression and increases exercise participation and performance in dogs with age-related muscle atrophy. Animals (Basel). 2024. PMID 38254356
- Dietary supplementation with ursolic acid preserves skeletal muscle mass and strength in mouse models of cancer cachexia. Am J Physiol Cell Physiol. 2026. PMID 42117587
- Ursolic acid alleviates cancer cachexia and prevents muscle wasting via activating SIRT1. Cancers (Basel). 2023. PMID 37190306
- Ursolic acid attenuates sarcopenia through IL-17a-related gut-muscle axis in senile diabetic mice and myotube model. J Nutr Biochem. 2025. PMID 40294722
- Muscle strength, lipid metabolism and hepatic steatosis are improved with ursolic acid treatment in high-fat diet-induced obese mice. Nutrients. 2025. PMID 41097235
- Short-term ursolic acid promotes skeletal muscle rejuvenation through enhancing of SIRT1 expression and satellite cells proliferation. Biomed Pharmacother. 2016. PMID 26898441
- Ursolic acid regulates aging process through enhancing of metabolic sensor proteins level. Biomed Pharmacother. 2016. PMID 27470332
- Ursolic acid in health and disease. Korean J Physiol Pharmacol. 2018. PMID 29719446
- Targeting autophagy by natural product ursolic acid for prevention and treatment of osteoporosis. Toxicol Appl Pharmacol. 2020. PMID 33065153
- Therapeutic potential of ursolic acid to manage neurodegenerative and psychiatric diseases. CNS Drugs. 2017. PMID 29098660
- DECR1 degradation by ursolic acid alleviates vascular calcification through inhibition of NF-κB/NLRP3 signaling pathway. Free Radic Biol Med. 2026. PMID 42034130
- Nanoparticles use for delivering ursolic acid in cancer therapy: a scoping review. Front Pharmacol. 2021. PMID 35002719
- A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors. Biomed Res Int. 2015. PMID 25866811
- Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic review. Obes Rev. 2017. PMID 28335087